Back to search
Schizophrenia Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophrenia Patients trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophrenia Patients trials you may qualify forThis study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMA…
This is a Phase 3, randomized, double blind, placebo controlled, fixed dose, study designed to evaluate the efficacy, safety, tolerability, and of LB-102 versus…
Cannabis use disorder is a frequent comorbidity of schizophrenia, associated with increased symptoms and less adherence to therapy. Validated care has limited e…
Schizophrenia is a common and severe mental disorder that imposes a significant burden on patients. Cognitive impairment can be regarded as one of the core symp…
This study will consist of 2 parts: Part Ⅰ-in healthy adult subjects, Part Ⅱ-in adult patients with schizophrenia
This is a double blind adjunctive randomized controlled trial for schizophrenia using acetazolamide.
This study aims to evaluate the effectiveness of Ashwagandha (Withania somnifera) extract as an adjuvant therapy in patients with schizophrenia who are receivin…
Phase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizo…
The combination of pharmacotherapy and individual cognitive behavioral therapy in a private practice.